Use of tafenoquine to treat a patient with relapsing babesiosis with clinical and molecular evidence of resistance to azithromycin and atovaquone
Sign Up to like & getrecommendations! Published in 2022 at "IDCases"
DOI: 10.1016/j.idcr.2022.e01460
Abstract: Tafenoquine is a highly effective treatment for Babesia microti infections in animal models. An immunocompromised patient infected by a strain of B. microti that was at least partially resistant to both azithromycin and atovaquone was… read more here.
Keywords: use tafenoquine; treat patient; azithromycin atovaquone; tafenoquine treat ... See more keywords
Babesiosis in Long Island: review of 62 cases focusing on treatment with azithromycin and atovaquone
Sign Up to like & getrecommendations! Published in 2017 at "Annals of Clinical Microbiology and Antimicrobials"
DOI: 10.1186/s12941-017-0198-9
Abstract: BackgroundBabesiosis is a potentially life-threatening, tick-borne infection endemic in New York. The purpose of this study was to review recent trends in babesiosis management and outcomes focusing on patients, who were treated with combination of… read more here.
Keywords: island review; azithromycin atovaquone; babesiosis long; treatment ... See more keywords